Biotechnological Medicines in the Russian Pharmaceutical Market: New Pharmacopeia Requirements and the Status of Restrictive Lists
| Autor: | Nana Uzovna Bekhorashvili, Maria Rayisyan, Rimma Yuiryevna Garankina, Elena Revovna Zakharochkina |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
genetically engineered human insulin preparations
business.industry Pharmaceutical market 030209 endocrinology & metabolism General Medicine erythropoietins 14th edition of the State Pharmacopoeia DNA vaccines National state interferons 03 medical and health sciences 0302 clinical medicine Medicine biological medicines monoclonal antibodies 030212 general & internal medicine Marketing business filgrastim list of vital and essential drugs health care economics and organizations biotechnological medicines |
| Zdroj: | Open Access Macedonian Journal of Medical Sciences; Vol. 8 No. E (2020): E-Public Health; 389-394 |
| ISSN: | 1857-9655 |
| DOI: | 10.3889/oamjms.2020.3636 |
| Popis: | The study is aimed at identifying the key aspects of the national pharmacopeial regulation of the circulation of biotechnological medicines in the Russian pharmaceutical market and at studying the range of major groups based on the analysis of restrictive lists. The systematic analysis of the new national State Pharmacopeia has resulted in the identification of the newly-introduced general pharmacopeia monographs on biotechnological medicines and their groups, establishing the monographs on specific items, and the generalization of the basic conditions for ensuring quality in production. The content analysis of the restrictive lists has made it possible to determine the vital and most important items by the main groups of biotechnological medicines. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|